Conference item icon

Conference item

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Subgroup:
Target Discovery Institute
ORCID:
0000-0002-9993-2478
Jenkins, C More by this author
Peterson, S More by this author
Bengtsson, T More by this author
Expand authors...
Publisher:
European Respiratory Society Publisher's website
Journal:
European Respiratory Journal Journal website
Volume:
52
Host title:
European Respiratory Journal
Publication date:
2018-11-19
DOI:
EISSN:
1399-3003
ISSN:
0903-1936
Pubs id:
pubs:967014
UUID:
uuid:7ffdef1a-54a2-45fd-8817-f0542e240133
Source identifiers:
967014
Local pid:
pubs:967014
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP